Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial.

Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial. J Clin Oncol. 2023 06 10; 41(17):3203-3216.

View in: PubMed

subject areas

Androgen Antagonists
Androgens
Combined Modality Therapy
Disease-Free Survival
Humans
Male
Prostate-Specific Antigen
Prostatic Neoplasms
Quality of Life
Radiotherapy Dosage

authors with profiles

Theodore Karrison